Inloggen
E-mail
Wachtwoord
Paswoord weergeven
Bewaren
Bent u uw wachtwoord vergeten?
Gratis lid worden
Registreer
Registreer
Instellingen
Instellingen
Dynamische koersen 
OFFON
  1. Homepagina
  2. Aandelen
  3. Verenigd Koninkrijk
  4. London Stock Exchange
  5. AstraZeneca PLC
  6. Onderneming
    AZN   GB0009895292

ASTRAZENECA PLC

(AZN)
OverzichtKoersenGrafiekenNieuwsRatingsAgendaOndernemingFinanciŽnConsensusHerzieningenBeursproducten 
Beroep
Logo AstraZeneca PLC
AstraZeneca PLC is een van 's werelds grootste farmaceutische concerns. De netto-omzet kan als volgt naar inkomstenbron worden uitgesplitst:

- productverkoop (97,3%). De netto-omzet is uitgesplitst naar behandelingsgebied: oncologie (41,9%), hart- en vaatziekten, nierziekten en stofwisselingsziekten (27,4%), luchtwegaandoeningen en auto-immuunziekten (20,7%), en overig (10%; ontstekingsziekten, neurologische ziekten, maag- en darmziekten en infectieziekten);

- samenwerkingsinkomsten (2,7%).

De netto-omzet is geografisch als volgt verdeeld: Verenigd Koninkrijk (6,5%), Continentaal Europa (18,2%), Noord- en Zuid-Amerika (38,7%) en Afrika/AziŽ/AustraliŽ (36,6%).

Aantal werknemers : 76 100 mensen.
Verkoop per activiteit
20192020Delta
Oncology6 793.7135.5%8 461.0039.3% +24.54%
Cardiovascular, Renal & Metabolism5 413.3328.3%5 533.5725.7% +2.22%
Respiratory4 225.7922.1%4 177.4719.4% -1.14%
Other Diseases2 038.8210.7%2 017.389.4% -1.05%
Externalisation Revenue641.983.4%566.932.6% -11.69%
GBP in miljoenen
Verkoop per regio
20192020Delta
United States6 307.7233%6 983.2532.5% +10.71%
China3 815.0420%4 168.1119.4% +9.25%
Japan1 976.8910.3%2 001.799.3% +1.26%
United Kingdom1 428.197.5%1 357.666.3% -4.94%
Other Asia, Africa and Australasia1 111.515.8%1 196.245.6% +7.62%
Other Continental Europe1 011.965.3%1 084.725% +7.19%
Sweden653.743.4%800.093.7% +22.39%
Germany551.842.9%730.693.4% +32.41%
Other Americas638.063.3%593.442.8% -6.99%
France453.072.4%509.222.4% +12.39%
Canada365.281.9%464.772.2% +27.24%
Italy310.411.6%336.101.6% +8.28%
Spain281.411.5%310.371.4% +10.29%
Australia208.511.1%219.911% +5.47%
GBP in miljoenen
Managers
Naam Titel Leeftijd Van
Pascal Soriot Chief Executive Officer & Executive Director 61 2012
Aradhana Sarin Chief Financial Officer & Executive Director 46 2021
Menelas Pangalos EVP-Biopharmaceuticals Research & Development 53 2019
Pam Cheng Executive VP-Operations & Information Technology 49 2015
Henry Cremisi Medical Director - -
Hasan Jafri Senior Medical Director - -
Katarina Ageborg Chief Compliance Officer & EVP-Sustainability - 2017
Marcus Wallenberg Independent Non-Executive Director 64 1999
Leif Johansson Non-Executive Chairman 69 2012
Philip Arthur John Broadley Senior Independent Non-Executive Director 59 2021
Bestuurders
Naam Titel Leeftijd Van
Leif Johansson Non-Executive Chairman 69 2012
Marcus Wallenberg Independent Non-Executive Director 64 1999
Pascal Soriot Chief Executive Officer & Executive Director 61 2012
Philip Arthur John Broadley Senior Independent Non-Executive Director 59 2021
Nazneen Rahman, Dr. Independent Non-Executive Director - 2017
Sherilyn McCoy Independent Non-Executive Director 61 2017
Deborah DiSanzo Independent Non-Executive Director 60 2017
Tony Mok, Dr. Independent Non-Executive Director 59 2019
Michel Demarť Independent Non-Executive Director 65 2019
Euan A. Ashley, Dr. Non-Executive Director - 2020
Aandelen
Stemming AantalPercentage vrij verhandelbaarBedrijfseigen aandelenDrijvend Totaal
Aandeel A 1 1 549 158 964 1 492 933 845 96.4% 0 0.0% 96.4%
Aandeelhouders
NaamAandelen%
Wellington Management Co. LLP 68 525 329 4,42%
Capital Research & Management Co. (World Investors) 56 102 804 3,62%
BlackRock Investment Management (UK) Ltd. 54 582 684 3,52%
Investor AB (Investment Company) 51 587 810 3,33%
The Vanguard Group, Inc. 43 410 000 2,80%
Norges Bank Investment Management 29 430 000 1,90%
BlackRock Fund Advisors 26 594 541 1,72%
Capital Research & Management Co. (Global Investors) 20 726 848 1,34%
BlackRock Advisors (UK) Ltd. 19 081 467 1,23%
SSgA Funds Management, Inc. 14 043 000 0,91%
Participaties
NaamAandelen%Totale waarde
ASTRAZENECA PHARMA INDIA LIMITED (506820) 18 750 000 75,0% 753 155 063 USD
ADC THERAPEUTICS SA (ADCT) 4 011 215 5,23% 116 285 123 USD
CIRCASSIA GROUP PLC (CIR) 71 081 217 17,0% 41 896 691 USD
INNATE PHARMA (IPH) 7 485 500 9,48% 41 857 643 USD
SILENCE THERAPEUTICS PLC (SLNCF) 4 397 247 4,90% 30 439 019 USD
PIERIS PHARMACEUTICALS, INC. (PIRS) 3 584 230 5,37% 16 415 773 USD
PHASEBIO PHARMACEUTICALS, INC. (PHAS) 3 004 554 6,25% 11 297 123 USD
INOZYME PHARMA, INC. (INZY) 1 109 910 4,69% 10 366 559 USD
ENTASIS THERAPEUTICS HOLDINGS INC. (ETTX) 2 164 855 4,58% 6 169 837 USD
ARIDIS PHARMACEUTICALS, INC. (ARDS) 884 956 7,30% 3 097 346 USD
Markten en indexen
- Main Market
- OMX Stockholm 30 / FTSE 100, FTSE 350, FTSE All-Share, FTSE Eurotop 100, Low Carbon 100 Europe, NASDAQ OMX Nordic 120, OMX Nordic 40, Stoxx Europe 50, STOXX Europe 600, Stoxx Global 200, Stoxx UK 50
Beurscodes
- Bloomberg-code :  AZN:LN
- Reuters Code :  AZN.L
- Datastreamcode :  AZN
Bedrijfsgegevens
AstraZeneca PLC
Cambridge Biomedical Campus 1 Francis Crick Avenue
CB2 0AA Cambridge, Cambridgeshire

Telefoon : +44 (0)20 3749 5000
Fax : +44 (0)20 7604 8151
Internet : https://www.astrazeneca.com/investor-relations.html
Merkenportefeuille
In samenwerking metMijn merken op de beurs
Meer merken vanAstraZeneca PLC
Sector Farmaceutische producten - Andere
Verschil t.o.v. 1 jan (%)Kapitalisatie (M$)
ASTRAZENECA PLC13.52%171 528
JOHNSON & JOHNSON0.44%416 161
ROCHE HOLDING AG18.38%343 323
PFIZER, INC.48.55%306 912
NOVO NORDISK A/S66.91%247 444
ELI LILLY AND COMPANY47.55%225 859
ABBVIE INC.8.18%204 915
MERCK & CO., INC.-9.00%188 031
NOVARTIS AG-11.25%180 565
SANOFI9.07%122 030
BRISTOL-MYERS SQUIBB COMPANY-11.41%121 969
AMGEN INC.-13.50%113 104
GLAXOSMITHKLINE PLC14.84%102 790
CHUGAI PHARMACEUTICAL CO., LTD.-33.40%52 902
JIANGSU HENGRUI MEDICINE CO., LTD.-47.18%50 537
BAYER AG-5.78%50 479
DAIICHI SANKYO COMPANY, LIMITED-19.69%48 101
TAKEDA PHARMACEUTICAL COMPANY LIMITED-19.49%41 547
ASTELLAS PHARMA INC.11.29%28 790
HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY44.16%23 918
CATALENT, INC.22.33%21 794